2-Aryladenine derivatives as a potent scaffold for adenosine receptor antagonists: the 6-Morpholino derivatives

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS)
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
dc.contributor.authorAreias, Filipe
dc.contributor.authorCorreia, Carla
dc.contributor.authorRocha, Ashly
dc.contributor.authorTeixeira, Sofia
dc.contributor.authorCastro Pérez, Marián
dc.contributor.authorBrea Floriani, José Manuel
dc.contributor.authorHu, Huabin
dc.contributor.authorCarlsson, Jens
dc.contributor.authorLoza García, María Isabel
dc.contributor.authorProença, M. Fernanda
dc.contributor.authorCarvalho, M. Alice
dc.date.accessioned2026-01-29T13:14:36Z
dc.date.available2026-01-29T13:14:36Z
dc.date.issued2024-05-28
dc.description.abstractA set of 2-aryl-9-H or methyl-6-morpholinopurine derivatives were synthesized and assayed through radioligand binding tests at human A1, A2A, A2B, and A3 adenosine receptor subtypes. Eleven purines showed potent antagonism at A1, A3, dual A1/A2A, A1/A2B, or A1/A3 adenosine receptors. Additionally, three compounds showed high affinity without selectivity for any specific adenosine receptor. The structure-activity relationships were made for this group of new compounds. The 9-methylpurine derivatives were generally less potent but more selective, and the 9H-purine derivatives were more potent but less selective. These compounds can be an important source of new biochemical tools and/or pharmacological drugs
dc.description.peerreviewedSI
dc.description.sponsorshipThis research was funded by the Portuguese Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência (MEC) through funds in the framework of the Strategic Funding of CQUM (UID/QUI/00686/2020), (UID/QUI/00686/2018), FEDER funds through the Operational Programme for Competitiveness Factors (COMPETE 2020), Programa Operacional de Competitividade e Internacionalização (POCI) (POCI-01-0145-FEDER-031354) Rede Nacional de RMN (PINFRA/22161/2016), and PhD grants to Carla Correia and Ashly Rocha (SFRH/BD/22270/2005; SFRH/BD/85937/2012), Xunta de Galicia (ED431C 2022/20), and the European Regional Development Fund (ERDF). Filipe Areias gratefully acknowledges the Post-PhD grant from the Portuguese FCT (SFRH/BPD/26106/2005). J.C. received funding from the Olle Engkvist Foundation (219-0154) and the Swedish Research Council (2021-4186). The LECO instrument for elemental analysis TruSpec Micro CHN was purchased within the PT-OPENSCREEN project (NORTE-01—0145-FEDER-085468), financed by CCDR-N
dc.identifier.citationAreias, F., Correia, C., Rocha, A., Teixeira, S., Castro, M., Brea, J., Hu, H., Carlsson, J., Loza, M. I., Proença, M. F., & Carvalho, M. A. (2024). 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives. Molecules, 29(11), 2543. https://doi.org/10.3390/molecules29112543
dc.identifier.doi10.3390/molecules29112543
dc.identifier.essn1420-3049
dc.identifier.urihttps://hdl.handle.net/10347/45595
dc.issue.number11
dc.journal.titleMolecules
dc.language.isoeng
dc.publisherMDPI
dc.relation.publisherversionhttps://doi.org/10.3390/molecules29112543
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectG protein-coupled receptors
dc.subjectAdenine derivatives
dc.subjectAdenosine receptor antagonists
dc.subject2-arylpurine derivatives
dc.subjectStructure-activity relationship
dc.title2-Aryladenine derivatives as a potent scaffold for adenosine receptor antagonists: the 6-Morpholino derivatives
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number29
dspace.entity.typePublication
relation.isAuthorOfPublication67b19be7-64a8-45c8-a6e4-ed48a4410ef8
relation.isAuthorOfPublication7765cb9b-b630-44dc-9477-dd266a62bb3c
relation.isAuthorOfPublication.latestForDiscovery67b19be7-64a8-45c8-a6e4-ed48a4410ef8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024_Mol_Areias_2Aryladenine.pdf
Size:
1.64 MB
Format:
Adobe Portable Document Format